Abstract LBA022: IMM20324, a First-in-class, Anti-Interleukin-38 Monoclonal Antibody, Rescues Myeloid Cell Activation in Vitro and Induces Robust Anti-Tumor Responses in Vivo
Molecular Cancer Therapeutics（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined